On July 7, 2025, Ascentage Pharma announced the appointments of Dr. Veet Misra as the company’s Chief Financial Officer and Mr. Eric Huang as Senior Vice President of Global Corporate Development and Finance. Both executives will report directly to Chairman & CEO Dr. Dajun Yang.
Dr. Misra brings over 20 years of investment banking experience in the biopharmaceutical sector, combined with a deep scientific background in biology. Mr. Huang has more than 20 years of managerial experience in multinational pharmaceutical companies, including Beigene and Novartis.
These appointments are intended to accelerate the implementation of Ascentage Pharma's global strategy as it enters a phase of notable growth. The new leadership aims to enhance financial management, strengthen global operations, and drive corporate development.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.